Each sample was tested in two technical replicates
Verhaeverbeke, 1997) One trial of predominantly vegetarian families from India (Deshmukh, 2010) One trial of half vegetarians and half vegans whose responses were mixed together (Del Bo, 2019) One trial of B12 supplementation in vegans who werent previously supplementing (Crane, 1998) The dotted lines represent the trial of only vegans (500 g per day by Crane et al.) and the trial of half vegetarians and half vegans (50 g and 2,000/wk by Del Bo, 2019)
Why a 4-Compound Multi-Pathway Blend KLOW 80mg is the highest-complexity research blend in the OL Research catalogue, combining four compounds across four distinct molecular mechanisms in a single co-lyophilised preparation: BPC-157 (10mg) angiogenesis (VEGF), nitric oxide pathway modulation, gastrointestinal mucosal repair GHK-Cu (50mg) copper-binding tripeptide
Thats where peptides come in
NAD First When: The primary complaint is fatigue, low energy, or feeling depleted for no identifiable reason Brain fog, difficulty with memory recall, or cognitive slowing that is affecting work or daily function Post-viral recovery (Long COVID, post-Lyme, or similar) where systemic cellular function feels compromised The patient wants a broad, foundational energy intervention before layering anything specific on top Peptides First When: The concern is specific and localized: hair thinning, skin laxity, tendon injury, gut inflammation, or body composition The patient wants to optimize performance in the gym, including muscle gain and fat loss (CJC/Ipamorelin, Tesamorelin, MOTS-C) The goal is targeted repair, for example post-procedure healing or scar reduction The patient is already energetic but wants to enhance a specific system or tissue Combination When: Fatigue AND difficulty concentrating: NAD + Semax addresses both the cellular energy deficit and the cognitive signaling layer Fatigue AND skin/hair concerns: NAD + GHK-Cu covers the systemic energy layer and the specific tissue signaling layer simultaneously The patient has multiple complaints that clearly fall into different categories Optimization patients who want to address cellular health comprehensively rather than one concern at a time What Patients Feel: NAD vs
The only human study of BPC-157s effects is small and lacks comparison to a placebo
